Valueworks LLC Amgen Inc Transaction History

Valueworks LLC

$322 Million
Q2 2024

A detailed history of Valueworks LLC transactions in Amgen Inc stock. As of the latest transaction made, Valueworks LLC holds 12,625 shares of AMGN stock, worth $4.03 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares

12,625

Previous 11,880 6.27%

Holding current value

$4.03 Million

Previous $3.38 Million 16.82%

% of portfolio

1.23%

Previous 1.1%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$262.75 - $319.31 $195,748 - $237,885	745 Added 6.27%	12,625 $3.95 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $28,231 - $34,078	105 Added 0.89%	11,880 $3.38 Million
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $91,796 - $103,557	-359 Reduced 2.96%	11,775 $3.39 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $75,434 - $93,653	-345 Reduced 2.76%	12,134 $3.26 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $4,285 - $5,067	20 Added 0.16%	12,479 $2.77 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $1,806 - $2,201	8 Added 0.06%	12,459 $3.01 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $33,209 - $42,196	-145 Reduced 1.15%	12,451 $3.27 Million
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $108,638 - $122,524	-484 Reduced 3.7%	12,596 $2.84 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $349,294 - $388,704	-1,514 Reduced 10.37%	13,080 $3.18 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $51,528 - $57,003	-235 Reduced 1.58%	14,594 $3.53 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $111,372 - $127,456	560 Added 3.92%	14,829 $3.34 Million
Q3 2021 Oct 19, 2021	BUY	$212.27 - $248.7 $212 - $248	1 Added 0.01%	14,269 $3.03 Million
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $28,029 - $31,096	-120 Reduced 0.83%	14,268 $3.48 Million
Q1 2021 May 25, 2021	BUY	$221.91 - $258.6 $7,766 - $9,051	35 Added 0.24%	14,388 $3.58 Million
Q4 2020 Feb 24, 2021	SELL	$216.38 - $257.67 $55,176 - $65,705	-255 Reduced 1.75%	14,353 $3.3 Million
Q3 2020 Nov 17, 2020	SELL	$234.65 - $260.95 $755,573 - $840,259	-3,220 Reduced 18.06%	14,608 $3.71 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $1.75 Million - $2.14 Million	-8,834 Reduced 33.13%	17,828 $4.21 Million
Q1 2020 May 19, 2020	SELL	$182.24 - $241.7 $1.3 Million - $1.73 Million	-7,152 Reduced 21.15%	26,662 $5.41 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $40.9 Million - $52.6 Million	-216,186 Reduced 86.47%	33,814 $8.15 Million
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $40.9 Million - $52.5 Million	215,927 Added 633.72%	250,000 $8.15 Million
Q3 2019 Nov 18, 2019	SELL	$174.11 - $208.62 $1.22 Million - $1.46 Million	-7,013 Reduced 17.07%	34,073 $6.59 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $198,706 - $232,928	1,192 Added 2.99%	41,086 $7.57 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $1.39 Million - $1.57 Million	-7,700 Reduced 16.18%	39,894 $7.58 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $85,632 - $99,960	-480 Reduced 1.0%	47,594 $92.7 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $378,176 - $426,344	-2,041 Reduced 4.07%	48,074 $9.97 Million
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $248,244 - $278,832	-1,495 Reduced 2.9%	50,115 $9.25 Million
Q1 2018 May 17, 2018	SELL	$169.43 - $198.0 $4,235 - $4,950	-25 Reduced 0.05%	51,610 $8.8 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $70,047 - $78,264	415 Added 0.81%	51,635 $8.98 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $45,168 - $51,570	270 Added 0.53%	51,220 $9.55 Million
Q2 2017 Aug 15, 2017	BUY	N/A	50,950	50,950 $8.78 Million

Others Institutions Holding AMGN

# of Institutions

3,084

Shares Held

417M

Call Options Held

7.18M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Valueworks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valueworks LLC with notifications on news.

Account